By Gregory Mannix, Vice President International Business Development, LSN
Life Science Nation (LSN) is thrilled to welcome McDermott Will & Emery as Title Sponsor of Healthtech Partnering Week (HPW) with two live workshops accessible to registered attendees of Redefining Early Stage Investments (RESI) and 4D Meets AI.
McDermott Will & Emery has brought valuable insights to LSN’s community of early-stage fundraising companies, investors, service providers, and strategic partnerships for years, and we look forward to bringing their content to the digital stage next week. There’s still time to register for HPW – Sign up for access to McDermott Will & Emery workshops and more!
Negotiating Term Sheets: What’s Best for the Company and What’s Best for You?
Live Workshop! March 16 | 1 PM EDT (Register for RESI Access)
Instructors:
- Nancy Briefs, President & CEO, AltrixBio, Inc.
- David Hendren, Managing Director, Augmentum Ventures
- Mark Mihanovic, Partner, McDermott Will & Emery
- Aroma Sharma, Partner, McDermott Will & Emery
This interactive workshop, organized and led by McDermott Will & Emery, will provide wisdom to early-stage CEOs and management on the latest trends in term sheets, with a focus on founder and management equity opportunities. The workshop will cover common issues of concern to entrepreneurs (valuation/dilution, liquidation preference, board makeup, protective provisions, anti-dilution). Experts from the legal, investment and entrepreneurial community will discuss the interplay of financing milestones in the term sheet discussion. Learn more!
How to Go to Market: Commercializing AI-Based Health Technologies
Live Workshop! March 19 | 10 AM EDT (Register for 4D Meets AI Access)
Instructors:
- Richie Bavasso, MBA, Co-Founder & CEO, nQ Medical Inc.
- Carolyn Metnick, JD, Partner, McDermott Will & Emery
- Michael Ryan, JD, Partner, McDermott Will & Emery
- Dale Van Demark, JD, Partner, McDermott Will & Emery
This workshop, hosted by our Title Sponsor McDermott Will & Emery, will focus on the various options for and the legal considerations involved with commercializing AI-based healthcare technologies, including regulatory and data strategies. Learn about the range of options, from R&D use to consumer products, from leading members of McDermott’s digital health practice and companies that have blazed the trail. Learn more!
Next Phase Newsletter 
Leave a Reply